EpiBone

Meet an Unreasonable Venture

Creating bone tissue from a patient's mesenchymal stem cells in vitro for use in bone grafts.

Nina Tandon

CEO & Co-Founder at EpiBone

More about Nina »

Connect

epibone.com

Employees 21–50

Headquarters Jersey City, New Jersey, United States

EpiBone, Inc. is privately-held clinical-stage regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of cells to create living solutions that can become a seamless part of a patient’s body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products.

Health

Currently Operating in One Region

Press Mentions

July 24, 2023

EpiBone to Start Clinical Trials for Knee Cartilage Grown in Lab

/PRNewswire/ -- EpiBone has received Investigational New Drug (IND) clearance from the FDA to begin testing its lab-grown knee cartilage in humans. The...

Read on PRNewswire »

October 25, 2023

Behind Nina Tandon — The Big Apple and the Biotech Founder

Nina Tandon, a biotech entrepreneur, shares her journey from growing up in New York City to founding her own company. She discusses the challenges she faced and the importance of diversity in the...

Read on Brown Girl Magazine »

March 9, 2023

EpiBone, emerging biotech company, is relocating to Jersey City — and bringing nearly 100 jobs | ROI-NJ

EpiBone, an emerging biotechnology company co-founded and run by Nina Marie Tandon, is coming to Jersey City after the Board of the New Jersey Economic Development Authority (NJEDA) approved up to...

Read on ROI-NJ »

October 17, 2015

Why Peter Thiel Invested In New York Biotech Startup EpiBone

EpiBone uses stem cells to regrow damaged bones. After getting a PhD from Columbia, Nina Tandon returned to school for an MBA to form a company at the forefront of 'biology as design.'

Read on Inc.com »